Summary
Patrick Grossmann is a CEO and entrepreneur with 12 years of experience at the intersection of data science, bioinformatics, and commercial strategy, currently scaling Invitris to transform DNA-to-protein engineering for next-generation therapeutics. He holds a PhD in Data Science and conducted doctoral research at Harvard Medical School and Dana-Farber, where he pioneered integrative radiogenomic and digital-phenotyping models for precision oncology. Combining an MBA with hands-on computational expertise, he translates complex multimodal biomedical data and NLP in digital health into viable, data-driven business models and products. His leadership spans fundraising, licensing, go-to-market strategy and team building, grounded in a track record of reproducible, translational research. Patrick favors international, collaborative environments and brings a rare blend of deep technical rigor and startup execution—an engineer who now runs the company bench-to-bedside. An unassuming detail: he actively leverages his academic network and reproducible pipelines to accelerate commercialization of high-risk bioengineering innovations.
12 years of coding experience
7 years of employment as a software developer
Master of Science - MSc Bioinformatics and Biostatistics, Master of Science - MSc Bioinformatics and Biostatistics at Bielefeld University
Abitur (Hochschulreife) Natural Sciences, Abitur (Hochschulreife) Natural Sciences at Lise-Meitner Gymnasium
Doctor of Philosophy - PhD Data Science, Doctor of Philosophy - PhD Data Science at Maastricht University
Y Combinator
Master of Business Administration - MBA Engineering, Master of Business Administration - MBA Engineering at Collège des Ingénieurs
English, German